Now showing items 1-5 of 5
Antirheumatic medicine prescribing patterns and direct medicine costs in the South African private health sector
Objectives To describe antirheumatic medicine prescribing patterns and to estimate the total annual direct medicine cost of rheumatoid arthritis (RA) in the private health sector of South Africa. Methods A retrospective, ...
Pilot of a pharmacoepidemiology capacity building electronic survey for the Latin American and African regions
Background: The ISPE Global Development Committee in collaboration with the Educational Committee and ISPE Board of Directors aims to build‐up pharmacoepidemiology (PE) research capacity in the Latin America (LatAm) and ...
Challenges and issues in drug utilization research identified from the Latin American and African regions
Background: Despite advancements in drug utilization research (DUR), these have not been universal. Some regions such as the Latin America (LatAm) and African regions are facing challenges that are impeding the development ...
Increasing access to drug utilization data globally: developing an action plan
Background: Drug utilization (DU) research intends to support health authorities in the development of evidence‐informed pharmaceutical policy and practice guidelines, with the interest of the patients and communities in ...
Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa
Introduction Little is known about the burden of rheumatoid arthritis (RA) in South Africa. The aim of this study was to establish the prevalence of RA and coexisting chronic disease list (CDL) conditions in the private ...